BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30090735)

  • 1. A Comparison of Clinicopathological Characteristics and Short-Term Outcome of Papillary Thyroid Carcinoma with Tall Cell Histology and Classic Papillary Thyroid Carcinoma: A Single-Institution Experience.
    Sampathkumar G; Nair V; Menon UV; Smitha NV; Sundaram S; Kumar H; Pavithran PV; Bhavani N; Menon AS; Abraham N; Pullikkal A
    Indian J Endocrinol Metab; 2018; 22(3):405-409. PubMed ID: 30090735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer.
    Scholfield DW; Fitzgerald CW; Alzumaili B; Eagan A; Xu B; Martinez G; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein RA; Ganly I
    Ann Surg Oncol; 2023 Aug; 30(8):4761-4770. PubMed ID: 37154968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
    Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
    Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
    Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the clinicopathological features and oncologic outcomes of the classic papillary thyroid carcinoma with tall cell features and tall cell variant.
    Kim K; Jung CK; Lim DJ; Bae JS; Kim JS
    Gland Surg; 2022 Jan; 11(1):56-66. PubMed ID: 35242669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
    J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.
    Lee SH; Jung CK; Bae JS; Jung SL; Choi YJ; Kang CS
    Diagn Cytopathol; 2014 Jan; 42(1):11-7. PubMed ID: 23754825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.
    Ghossein RA; Leboeuf R; Patel KN; Rivera M; Katabi N; Carlson DL; Tallini G; Shaha A; Singh B; Tuttle RM
    Thyroid; 2007 Jul; 17(7):655-61. PubMed ID: 17696836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
    Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
    Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases.
    Regalbuto C; Malandrino P; Tumminia A; Le Moli R; Vigneri R; Pezzino V
    Thyroid; 2011 Apr; 21(4):383-9. PubMed ID: 21309722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
    Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
    Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
    Rivera M; Tuttle RM; Patel S; Shaha A; Shah JP; Ghossein RA
    Thyroid; 2009 Feb; 19(2):119-27. PubMed ID: 19191744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Aggressive Variant Histology Without Invasive Features Predict Overall Survival in Papillary Thyroid Cancer?: A National Cancer Database Analysis.
    Limberg J; Ullmann TM; Stefanova D; Buicko JL; Finnerty BM; Zarnegar R; Fahey TJ; Beninato T
    Ann Surg; 2021 Sep; 274(3):e276-e281. PubMed ID: 31599802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
    Li C; Lee KC; Schneider EB; Zeiger MA
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4559-70. PubMed ID: 23055546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes.
    Regalbuto C; Malandrino P; Frasca F; Pellegriti G; Le Moli R; Vigneri R; Pezzino V
    J Endocrinol Invest; 2013 Apr; 36(4):249-54. PubMed ID: 22776915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Sep; 459(3):265-76. PubMed ID: 21796448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
    Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
    J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome.
    Lang BH; Lo CY; Chan WF; Lam AK; Wan KY
    World J Surg; 2006 May; 30(5):752-8. PubMed ID: 16680590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.